Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use

[1]  D. Tanné,et al.  Antithrombotic Treatment Prior to Intracerebral Hemorrhage: Analysis in the National Acute Stroke Israeli Registry. , 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[2]  A. Alexandrov,et al.  Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral Hemorrhage , 2018, Stroke.

[3]  A. Alexandrov,et al.  Neuroimaging and clinical outcomes of oral anticoagulant–associated intracerebral hemorrhage , 2018, Annals of neurology.

[4]  Eric E. Smith,et al.  Association of Intracerebral Hemorrhage Among Patients Taking Non–Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality , 2018, JAMA.

[5]  E. Berge,et al.  Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. , 2018, The Cochrane database of systematic reviews.

[6]  A. Alexandrov,et al.  Direct oral anticoagulant– vs vitamin K antagonist–related nontraumatic intracerebral hemorrhage , 2017, Neurology.

[7]  J. Jeng,et al.  Outcome of intracerebral hemorrhage associated with different oral anticoagulants , 2017, Neurology.

[8]  E. Cuadrado Godia,et al.  Antithrombotic pretreatment increases very-early mortality in primary intracerebral hemorrhage , 2017, Neurology.

[9]  W. Hacke,et al.  Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial , 2016, The Lancet Neurology.

[10]  A. Demchuk,et al.  Magnitude of Hematoma Volume Measurement Error in Intracerebral Hemorrhage , 2016, Stroke.

[11]  D. Werring,et al.  Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type , 2016, Neurology.

[12]  M. Mehdorn,et al.  Clinical and radiological course of intracerebral haemorrhage associated with the new non-vitamin K anticoagulants , 2016, Acta Neurochirurgica.

[13]  C. Anderson,et al.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2015, Stroke.

[14]  F. Pomero,et al.  Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage , 2015, Annals of neurology.

[15]  G. Fink,et al.  Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. , 2015, JAMA.

[16]  D. Krieger,et al.  European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage , 2014, International journal of stroke : official journal of the International Stroke Society.

[17]  Jiming Liu,et al.  Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range , 2014, BMC Medical Research Methodology.

[18]  M. Kaste,et al.  Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use , 2014, European journal of neurology.

[19]  Erika G Cordova,et al.  Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation. , 2014, The Cochrane database of systematic reviews.

[20]  Michael Tin Chung Poon,et al.  Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  G. Hankey,et al.  Stroke Unit Care Benefits Patients With Intracerebral Hemorrhage: Systematic Review and Meta-analysis , 2013, Stroke.

[22]  A. Meretoja,et al.  Warfarin-associated intracerebral hemorrhage: Volume, anticoagulation intensity and location , 2013, Journal of the Neurological Sciences.

[23]  E. Berge,et al.  Factor Xa Inhibitors Versus Vitamin K Antagonists for Prevention of Cerebral or Systemic Embolism in Patients With Atrial Fibrillation , 2018, The Cochrane database of systematic reviews.

[24]  M. Woodward,et al.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.

[25]  W. Hacke,et al.  Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study , 2013, Journal of Neurology.

[26]  D. Leys,et al.  Vitamin K Antagonists–Associated Cerebral Hemorrhages: What Are Their Characteristics? , 2013, Stroke.

[27]  K. Butcher,et al.  Poor Prognosis in Warfarin-Associated Intracranial Hemorrhage Despite Anticoagulation Reversal , 2012, Stroke.

[28]  A. Demchuk,et al.  Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study , 2012, The Lancet Neurology.

[29]  Eric E. Smith,et al.  Defining hematoma expansion in intracerebral hemorrhage , 2011, Neurology.

[30]  K. Kimura,et al.  Prior oral antithrombotic therapy is associated with early death in patients with supratentorial intracerebral hemorrhage. , 2011, Internal medicine.

[31]  C. Anderson,et al.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2010, Stroke.

[32]  W. Hacke,et al.  Point‐of‐care reversal treatment in phenprocoumon‐related intracerebral hemorrhage , 2010, Annals of neurology.

[33]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[34]  K. Nagata,et al.  Antithrombotic Therapy Influences Location, Enlargement, and Mortality from Intracerebral Hemorrhage , 2008, Cerebrovascular Diseases.

[35]  S. Kasner,et al.  Hematoma Growth in Oral Anticoagulant Related Intracerebral Hemorrhage , 2008, Stroke.

[36]  J. Broderick,et al.  Warfarin use leads to larger intracerebral hematomas , 2008, Neurology.

[37]  M. Shamji,et al.  Modifiable risk factors for intracerebral hemorrhage: study of anticoagulated patients. , 2008, Canadian family physician Medecin de famille canadien.

[38]  T. Neumann-Haefelin,et al.  Pretreatment With Antiplatelet Agents Is Not Independently Associated With Unfavorable Outcome in Intracerebral Hemorrhage , 2006, Stroke.

[39]  J. Broderick,et al.  Location and outcome of anticoagulant-associated intracerebral hemorrhage , 2006, Neurocritical care.

[40]  S. Greenberg,et al.  Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage , 2004, Neurology.

[41]  D. Singer,et al.  The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. , 2004, Archives of internal medicine.

[42]  P. Ingrand,et al.  Intracranial Hemorrhage and Oral Anticoagulant Treatment , 2001, Cerebrovascular Diseases.

[43]  G. Manley,et al.  The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. , 2001, Stroke.

[44]  J. Broderick,et al.  Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality , 1993, Stroke.

[45]  J. Olsson,et al.  Prognostic Parameters in Spontaneous Intracerebral Hematomas with Special Reference to Anticoagulant Treatment Subjects and Methods , 2022 .